These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

649 related articles for article (PubMed ID: 26240227)

  • 1. Prediction of Allogeneic Hematopoietic Stem-Cell Transplantation Mortality 100 Days After Transplantation Using a Machine Learning Algorithm: A European Group for Blood and Marrow Transplantation Acute Leukemia Working Party Retrospective Data Mining Study.
    Shouval R; Labopin M; Bondi O; Mishan-Shamay H; Shimoni A; Ciceri F; Esteve J; Giebel S; Gorin NC; Schmid C; Polge E; Aljurf M; Kroger N; Craddock C; Bacigalupo A; Cornelissen JJ; Baron F; Unger R; Nagler A; Mohty M
    J Clin Oncol; 2015 Oct; 33(28):3144-51. PubMed ID: 26240227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of Hematopoietic Stem Cell Transplantation Related Mortality- Lessons Learned from the In-Silico Approach: A European Society for Blood and Marrow Transplantation Acute Leukemia Working Party Data Mining Study.
    Shouval R; Labopin M; Unger R; Giebel S; Ciceri F; Schmid C; Esteve J; Baron F; Gorin NC; Savani B; Shimoni A; Mohty M; Nagler A
    PLoS One; 2016; 11(3):e0150637. PubMed ID: 26942424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the acute leukemia-EBMT score for prediction of mortality following allogeneic stem cell transplantation in a multi-center GITMO cohort.
    Shouval R; Bonifazi F; Fein J; Boschini C; Oldani E; Labopin M; Raimondi R; Sacchi N; Dabash O; Unger R; Mohty M; Rambaldi A; Nagler A
    Am J Hematol; 2017 May; 92(5):429-434. PubMed ID: 28181279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring of minimal residual disease after allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia allows for the identification of impending relapse: results of the ALL-BFM-SCT 2003 trial.
    Bader P; Kreyenberg H; von Stackelberg A; Eckert C; Salzmann-Manrique E; Meisel R; Poetschger U; Stachel D; Schrappe M; Alten J; Schrauder A; Schulz A; Lang P; Müller I; Albert MH; Willasch AM; Klingebiel TE; Peters C
    J Clin Oncol; 2015 Apr; 33(11):1275-84. PubMed ID: 25605857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-based prediction algorithm of relapse after allo-HSCT for acute Leukemia and its usefulness in the decision-making process using a machine learning approach.
    Fuse K; Uemura S; Tamura S; Suwabe T; Katagiri T; Tanaka T; Ushiki T; Shibasaki Y; Sato N; Yano T; Kuroha T; Hashimoto S; Furukawa T; Narita M; Sone H; Masuko M
    Cancer Med; 2019 Sep; 8(11):5058-5067. PubMed ID: 31305031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem-cell transplantation in children with acute lymphoblastic leukemia: A prospective international multicenter trial comparing sibling donors with matched unrelated donors-The ALL-SCT-BFM-2003 trial.
    Peters C; Schrappe M; von Stackelberg A; Schrauder A; Bader P; Ebell W; Lang P; Sykora KW; Schrum J; Kremens B; Ehlert K; Albert MH; Meisel R; Matthes-Martin S; Gungor T; Holter W; Strahm B; Gruhn B; Schulz A; Woessmann W; Poetschger U; Zimmermann M; Klingebiel T
    J Clin Oncol; 2015 Apr; 33(11):1265-74. PubMed ID: 25753432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of HLA-matched related allogeneic hematopoietic stem cell transplantation for patients with acute leukemia in first complete remission treated in Eastern European centers. Better results in recent years.
    Giebel S; Labopin M; Holowiecki J; Labar B; Komarnicki M; Koza V; Masszi T; Mistrik M; Lange A; Hellmann A; Vitek A; Pretnar J; Mayer J; Rzepecki P; Indrak K; Wiktor-Jedrzejczak W; Wojnar J; Krawczyk-Kulis M; Kyrcz-Krzemien S; Rocha V
    Ann Hematol; 2009 Oct; 88(10):1005-13. PubMed ID: 19301005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Who is the best hematopoietic stem-cell donor for a male patient with acute leukemia?
    Ringdén O; Labopin M; Solders M; Beelen D; Arnold R; Ehninger G; Milpied N; Niederwieser D; Hamladji RM; Kyrcz-Krzemien S; Ganser A; Socié G; Stelljes M; Volin L; Craddock C; Mohty M;
    Transplantation; 2014 Sep; 98(5):569-77. PubMed ID: 24798307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of second hematopoietic stem cell transplantation using reduced-intensity conditioning with fludarabine and melphalan after a failed autologous hematopoietic stem cell transplantation.
    Hong JY; Choi MK; Kim DH; Kim SJ; Kim K; Kim WS; Chung CW; Kim HO; Min YH; Jang JH
    Transplant Proc; 2010 Nov; 42(9):3723-8. PubMed ID: 21094846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia in Europe 2006: transplant activity, long-term data and current results. An analysis by the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Gratwohl A; Brand R; Apperley J; Crawley C; Ruutu T; Corradini P; Carreras E; Devergie A; Guglielmi C; Kolb HJ; Niederwieser D;
    Haematologica; 2006 Apr; 91(4):513-21. PubMed ID: 16533723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective evaluation of allogeneic hematopoietic stem-cell transplantation from matched related and matched unrelated donors in younger adults with high-risk acute myeloid leukemia: German-Austrian trial AMLHD98A.
    Schlenk RF; Döhner K; Mack S; Stoppel M; Király F; Götze K; Hartmann F; Horst HA; Koller E; Petzer A; Grimminger W; Kobbe G; Glasmacher A; Salwender H; Kirchen H; Haase D; Kremers S; Matzdorff A; Benner A; Döhner H
    J Clin Oncol; 2010 Oct; 28(30):4642-8. PubMed ID: 20805454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Machine learning for prediction of 30-day mortality after ST elevation myocardial infraction: An Acute Coronary Syndrome Israeli Survey data mining study.
    Shouval R; Hadanny A; Shlomo N; Iakobishvili Z; Unger R; Zahger D; Alcalai R; Atar S; Gottlieb S; Matetzky S; Goldenberg I; Beigel R
    Int J Cardiol; 2017 Nov; 246():7-13. PubMed ID: 28867023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
    Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clofarabine/cyclophosphamide for debulking before stem cell transplantation.
    Rabitsch W; Böhm A; Bojic M; Schellongowski P; Wöhrer S; Sliwa T; Keil F; Worel N; Greinix H; Hauswirth A; Kalhs P; Jaeger U; Valent P; Sperr WR
    Eur J Clin Invest; 2014 Aug; 44(8):775-83. PubMed ID: 24942362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using a machine learning algorithm to predict acute graft-versus-host disease following allogeneic transplantation.
    Arai Y; Kondo T; Fuse K; Shibasaki Y; Masuko M; Sugita J; Teshima T; Uchida N; Fukuda T; Kakihana K; Ozawa Y; Eto T; Tanaka M; Ikegame K; Mori T; Iwato K; Ichinohe T; Kanda Y; Atsuta Y
    Blood Adv; 2019 Nov; 3(22):3626-3634. PubMed ID: 31751471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive care unit support and Acute Physiology and Chronic Health Evaluation III performance in hematopoietic stem cell transplant recipients.
    Afessa B; Tefferi A; Dunn WF; Litzow MR; Peters SG
    Crit Care Med; 2003 Jun; 31(6):1715-21. PubMed ID: 12794410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. External validation and comparison of multiple prognostic scores in allogeneic hematopoietic stem cell transplantation.
    Shouval R; Fein JA; Shouval A; Danylesko I; Shem-Tov N; Zlotnik M; Yerushalmi R; Shimoni A; Nagler A
    Blood Adv; 2019 Jun; 3(12):1881-1890. PubMed ID: 31221661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Favorable outcomes after allogeneic hematopoietic stem cell transplantation in children with high-risk or advanced acute myeloid leukemia.
    Koh KN; Park M; Kim BE; Bae KW; Im HJ; Seo JJ
    J Pediatr Hematol Oncol; 2011 May; 33(4):281-8. PubMed ID: 21464766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hematopoietic cell transplantation-specific comorbidity index fails to predict outcomes in high-risk AML patients undergoing allogeneic transplantation--investigation of potential limitations of the index.
    Birninger N; Bornhäuser M; Schaich M; Ehninger G; Schetelig J
    Biol Blood Marrow Transplant; 2011 Dec; 17(12):1822-32. PubMed ID: 21708108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
    Duarte RF; Canals C; Onida F; Gabriel IH; Arranz R; Arcese W; Ferrant A; Kobbe G; Narni F; Deliliers GL; Olavarría E; Schmitz N; Sureda A
    J Clin Oncol; 2010 Oct; 28(29):4492-9. PubMed ID: 20697072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.